Manufacturer of drugs. The company develops early stage compounds used in the treatment of small cell lung cancer ("SCLC").
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore DDP Therapeutics‘s full profile, request access.
Request a free trialName | Title | Board Seat | Contact Info |
---|---|---|---|
J.L. Scott Baker | Chief Executive Officer & President |